GIRJAVALLABHAN, Vinay,NJOROGE, F. George,BOGEN, Stephane,VERMA, Vishal,BENNETT, Frank,KEREKES, Angela,ARASAPPAN, Ashok,PISSARNITSKI, Dimitri,DANG, Qun,DAVIES, Ian,OLSEN, David, B.,STAMFORD, Andrew,VACCA, Joseph, P.
申请号：
EP20120771566
公开号：
EP2696681(B1)
申请日:
2012.04.11
申请国别(地区):
欧洲专利局
年份:
2018
代理人:
摘要：
The present invention relates to 2′-Substituted Nucleoside Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, X, R1, R2 and R3 are as defined herein. The present invention also relates to compositions comprising at least one 2′-Substituted Nucleoside Derivative, and methods of using the 2′-Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.
